Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme

Journal of Virology

Volumn 79, Issue 20, 2005, Pages 12914-12920

  Simsek, Ender ^a   Mehta, Anand ^b   Zhou, Tianlun ^c   Dwek, Raymond A ^d   Block, Timothy ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c BARUCH S BLUMBERG INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXOMICIN; GLUCOSIDASE; LACTACYSTIN; PROTEASOME; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SECRETION; TISSUE CULTURE;

ACETYLCYSTEINE; CELL LINE; CYSTEINE PROTEINASE INHIBITORS; ENDOPLASMIC RETICULUM; GENE PRODUCTS, ENV; GLUCOSIDASES; HEPATITIS B VIRUS; HUMANS; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 26444569334     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.20.12914-12920.2005     Document Type: Article

References (33)

1. Baumeister, W., J. Walz, F. Zuhl, and E. Seemuller. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380.
2. Bergeron, J. J., M. B. Brenner, D. Y. Thomas, and D. B. Williams. 1994. Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem. Sci. 19:124-128.
3. Block, T. M., X. Lu, F. M. Platt, G. R. Foster, W. H. Gerlich, B. S. Blumberg, and R. A. Dwek. 1994. Hepatitis B virus secretion is inhibited by the imino sugar N-butyl-deoxynojirimycin. Proc. Natl. Acad. Sci. USA 91:2235-2239.
4. Block, T. M., X. Lu, A. S. Mehta, B. S. Blumberg, B. Tennant, M. Ebling, B. Korba, D. M. Lansky, G. S. Jacob, and R. A. Dwek. 1998. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat. Med. 4:610-614.
5. Block, T. M., and R. Jordan. 2002. Imino sugars as possible broad spectrum anti hepatitis virus agents: the alkovirs and glucovirs. Antiviral Chem. Chemother. 12:317-326.
6. Block, T. M., A. S. Mehta, C. J. Fimmel, and R. Jordan. 2003. Molecular viral oncology of hepatocellular carcinoma. Oncogene 22:5093-5107.
7. Bruss, V., and D. Ganem. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. USA 88:1059-1063.
8. De Virgilio, M., H. Weninger, and N. E. Ivessa. 1998. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome. J. Biol. Chem. 273:9734-9743.
9. Foster, A., and C. P. Hill. 2003. Proteasome degradation: enter the substrate. Trends Cell Biol. 13:550-553.
10. Ganem, D. 1991. Assembly of hepadnaviral virons and subviral particles. Curr. Top. Microbiol. Immunol. 168:61-84.
11. Gerlich, W. H., and K. H. Heermann. 1991. Functions of hepatitis B virus proteins and virus assembly, p. 121-131. In F. B. W. Hollinger, S. M. Lemon, and H. S. Margolis (ed.), Viral hepatitis and liver disease. Williams and Wilkins, Baltimore, Md.
12. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82:373-428.
13. Heermann, K. H., F. Kruse, M. Seiger, and W. H. Gerlich. 1987. Immunogenicity of S and pre-S domains in hepatitis virions and HBsAg filaments. Intervirology 28:14-25.
14. Heermann, K. H., and W. H. Gerlich. 1992. Surface proteins of hepatitis B viruses, p. 109-143. In A. MacLachlan (ed.), A molecular biology of hepatitis viruses. CRC, Boca Raton, Fla.
15. Hirsch, C., D. Blom, and H. L. Ploegh. 2003. A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J. 22:1036-1046.
16. Hoofnagle, J. H., and A. M. Di Bisceglie. 1997. Drug therapy: the treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
17. Lu, X., A. Mehta, R. Dwek, T. Butters, and T. Block. 1995. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virology 213:660-665.
18. Lu, X., A. Mehta, M. Dadmarz, R. Dwek, B. S. Blumberg, and T. M. Block. 1997. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proc. Natl. Acad. Sci. USA 94:2380-2385.
19. Lu, X., Y. Lu, R. Geschwindt, R. A. Dwek, and T. M. Block. 2001. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum. DNA Cell Biol. 20:647-656.
20. Mehta, A., X. Lu, T. M. Block, B. S. Blumberg, and R. A. Dwek. 1997. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA 94:1822-1827.
21. Mehta, A., P. M. Rudd, T. M. Block, and R. A. Dwek. 1997. A strategy for anti-viral intervention: the use of alpha-glucosidase inhibitors to prevent chaperone-mediated folding of viral envelope glycoproteins. Biochem. Soc Trans. 25:1188-1193.
22. Mehta, A., N. Zitzmann, P. M. Rudd, T. M. Block, and R. A. Dwek. 1998. Alpha-glucosidase inhibitors as potential broad based anti-viral agents. FEBS Lett. 430:17-22.
23. Norton, P. A., B. Conyers, Q. Gong, L. F. Steel, T. M. Block, and A. S. Mehta. 2005. Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker. J. Virol. Methods 124:167-172.
24. Prange, R., M. Werr, and M. H. Loffler. 1999. Chaperons involved in hepatitis B virus morphogenesis. Biol. Chem. 380:305-314.
25. Rabouille, C., and R. G. Spiro. 1992. Nonselective utilization of the endomannosidase pathway for processing glycoproteins by human hepatoma (HepG2) cells. J. Biol. Chem. 267:11573-11578.
26. Robinson, W. S., D. A. Clayton, and R. L. Greenman. 1974. DNA of a human hepatitis B virus candidate. J. Virol. 14:384-391.
27. Robinson, W. S. 1990. Hepadnaviridae and their replication, p. 2137-2169. In B. N. Fields, D. M. Knipe et al. (ed.), Fields virology. Raven Press, Ltd., New York, N.Y.
28. Rudd, P. M., T. Elliott, P. Cresswell, I. A. Wilson, and R. A. Dwek. 2001. Glycosylation and the immune system. Science 291:2370-2375.
29. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1998. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
30. Tan, A., L. van den Broek, S. van Broeckel, H. Ploegh, and J. Bolscher. 1991. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. J. Biol. Chem. 22:14504-14510.
31. Tan, A., L. van den Broek, J. Bolscher, D. J. Vermaas, L. Pastoors, C. van Boeckel, and H. Ploegh. 1994. Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharides. Glycobiology 4:141-149.
32. Xu, Z., V. Bruss, and T. S. Benedict Yen. 1997. Formation of intracellular particles by hepatitis B virus large surface protein. J. Virol. 71:5487-5494.
33. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class 1 major histocompatibility complex. Annu. Rev. Immunol. 4:369-396.